Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
8.72
+0.43 (5.19%)
At close: Nov 7, 2025, 4:00 PM EST
8.73
+0.01 (0.11%)
After-hours: Nov 7, 2025, 7:59 PM EST

ARCT Revenue

Arcturus Therapeutics Holdings had revenue of $28.30M in the quarter ending June 30, 2025, a decrease of -43.24%. This brings the company's revenue in the last twelve months to $122.12M, down -25.47% year-over-year. In the year 2024, Arcturus Therapeutics Holdings had annual revenue of $152.31M, down -8.69%.

Revenue (ttm)
$122.12M
Revenue Growth
-25.47%
P/S Ratio
1.93
Revenue / Employee
$693,875
Employees
176
Market Cap
236.79M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024152.31M-14.49M-8.69%
Dec 31, 2023166.80M-39.20M-19.03%
Dec 31, 2022206.00M193.64M1,566.79%
Dec 31, 202112.36M2.82M29.56%
Dec 31, 20209.54M-11.25M-54.12%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro